ZURA
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Zura Bio exceeded enrollment targets in two Phase 2 studies and expanded its tibulizumab programJun 29, 2026
- Zura Bio presented the Phase 2 TibuSURE study design evaluating dual IL-17A and BAFF inhibition in systemic sclerosisMar 5, 2026
- Zura Bio launches global Phase 2 TibuSHIELD study to evaluate Tibulizumab in adults with hidradenitis suppurativa.May 20, 2025